Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.

Lustman, P J; Griffith, L S; Clouse, R E; Freedland, K E; Eisen, S A; Rubin, E H; Carney, R M; McGill, J B

Lustman, P J; Griffith, L S; Clouse, R E; Freedland, K E; Eisen, S A; Rubin, E H; Carney, R M; McGill, J B.

Affiliation

Lustman PJ; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Diabetes Care ; 18(8): 1133-9, 1995 Aug.

Article in En | MEDLINE | ID: mdl-7587848

Subject(s)

Alprazolam/therapeutic use; Anti-Anxiety Agents/therapeutic use; Anxiety Disorders/drug therapy; Blood Glucose/metabolism; Diabetes Complications; Glycated Hemoglobin/analysis; Adult; Analysis of Variance; Anxiety; Blood Glucose/drug effects; Demography; Diabetes Mellitus/psychology; Diabetes Mellitus, Type 1/complications; Diabetes Mellitus, Type 1/psychology; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/psychology; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Placebos

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Anxiety Disorders / Anti-Anxiety Agents / Blood Glucose / Alprazolam / Glycated Hemoglobin / Diabetes Complications Type of study: Clinical_trials / Guideline / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 1995 Type: Article

Search on Google

XML

PubMed Links